Date:
16 May
Opportunities to Leverage Non-clinical Data in a Regulatory Integrated QTc Assessment
Presented by: Derek Leishman, Vice President, Translational and Quantitative Toxicology, Eli Lilly and Company
A Clinically Translatable hIPSC Cardiomyocyte Model to Predict QTc and QRS Cardiac Risk
Presented by: Steve Jenkinson, Vice President, Drug Discovery and Safety, Metrion Biosciences
Venue and Location Information:
Webinar
Event Registration Link: